A Look At Repligen (RGEN) Valuation As Ordering Stabilizes And Growth Segments Progress [Yahoo! Finance]
Repligen Corporation (RGEN)
Last repligen corporation earnings: 2/20 07:30 am
Check Earnings Report
US:NASDAQ Investor Relations:
repligen.com/investors
Company Research
Source: Yahoo! Finance
Repligen (RGEN) has drawn investor attention after management pointed to incremental stabilization in ordering from large and mid-sized biopharma customers, along with continued momentum in gene therapy and advanced biologics product lines. See our latest analysis for Repligen. Despite the update on stabilizing orders and growth areas, Repligen's 7 day share price return of 8.71% and 30 day share price return of 13.77% show fading short term momentum. Meanwhile, the 1 year total shareholder return of 9.77% and 3 year total shareholder return of 23.68% underline a tougher longer term stretch. If you are reassessing opportunities in life sciences after Repligen's recent moves, it could be a good moment to check out healthcare stocks as potential additions to your watchlist. With Repligen trading at US$146.11 alongside an indicated intrinsic discount of about 37% and a roughly 31% gap to the average analyst price target, you have to ask: is this genuine value, or is the market a
Show less
Read more
Impact Snapshot
Event Time:
RGEN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
RGEN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
RGEN alerts
High impacting Repligen Corporation news events
Weekly update
A roundup of the hottest topics
RGEN
News
- 3 Volatile Stocks Walking a Fine Line [Yahoo! Finance]Yahoo! Finance
- Repligen (NASDAQ:RGEN) was downgraded by analysts at <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a> from a "hold (c-)" rating to a "sell (d+)" rating.MarketBeat
- 2 Cash-Producing Stocks to Target This Week and 1 We Ignore [Yahoo! Finance]Yahoo! Finance
- UBS Tags Repligen (RGEN) as Bioprocessing Leader for 2026, Cites 20% Order Growth and Reshoring Tailwinds [Yahoo! Finance]Yahoo! Finance
- ???????????????????????2026:??????????????? [CNET News]CNET News
RGEN
Earnings
- 10/28/25 - Beat
RGEN
Sec Filings
- 2/5/26 - Form SCHEDULE
- 1/12/26 - Form 4
- 1/12/26 - Form 3
- RGEN's page on the SEC website